Wolfram sendromu tanısı alan iki kardeş olgunun retrospektif incelemesi
Wolfram sendromu 1/770000 oranında görülen patogenezi tam olarak bilinmeyen otozomal resesif kalıtımlı, dismorfogenetik bir hastalıktır. DİDMOAD sendromu olarak da adlandırılır. Başlıca diabetes mellitus, diabetes insipitus, optik atrofi ve sağırlıkla karakterizedir. Bu yazıda, Wolfram sendromu tanısı konulup takip edilen 8 ve 14 yaşlarındaki iki erkek kardeş sunuldu. On dört yaşındaki olgu 7 yıldır tip 1 diabetes mellitus tanısıyla izlenmekte iken, yapılan muayene ve laboratuar tetkiklerinde nörojen mesane ve işitme kaybının eşlik ettiği tespit edildi. Sekiz yaşında olan olguda ise 3 yıldır tip 1 diabetes mellitus, yaklaşık 2 yıldır diabetes insipitus tanılarıyla takip ediliyordu. Ayrıca işitme ve görmede azalma ile nörojen mesane varlığı söz konusuydu. Wolfram sendromu otozomal resesif geçiş gösterdiğinden, erken tanı için ailenin diğer fertlerinde bu hastalık olabileceği göz önünde bulundurularak, aile taraması yapılması gerekliliği vurgulandı.
Retrospective analysis of two brothers with the diagnosis of Wolfram syndrome
Wolfram syndrome, seen in 1/770000 of the population is an autosomal recessive dysmorphogenetical disease with unknown pathogenesis. It is characterized with the association of diabetes mellitus, diabetes insipidus, optic atrophy and deafness, and also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness). We present two brothers aged 8 and 14 years followed-up with the diagnosis of Wolfram syndrome in this article. Physical and laboratory exam revealed neurogenic bladder and deafness in the 14-year-old one who had been followed-up with juvenile-onset diabetes mellitus for 7 years. The other brother had been followed-up with the diagnosis of juvenile diabetes mellitus and diabetes insipidus for 3 and 2 years, respectively. He also had deafness, optic defect and neurogenic bladder. We emphasize the importance of family screening regarding the early diagnosis of Wolfram syndrome in the other individuals of the family since the disease shows an autosomal recessive inheritance.
___
- 1) Lin CH, Lee YJ, Huang CY et al. Wolfram (DIDMOAD) syndrome: report of two patients. J Pediatr Endocrinol Metab. 2004; 17:1461-1464.
- 2) Ribeiro MR, Crispim F, Vendramini MF, Moisés RS. Wolfram syndrome: from definition to molecular bases. Arq Bras Endocrinol Metabol. 2006 ;50:839-844.
- 3) Hernandez-Mijares A, Morillas C, Lluch, et al. Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care. 1999; 22:1378-1379.
- 4) Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Adult-onset type 1 diabetes with DIDMOAD syndrome-like manifestations. Arch Intern Med. 2001; 161:767-768.
- 5) Alemzadeh R, Wyatt DT. Diabetes mellitus in children. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17th ed. Philadelphia:WB Saunders Company 2004. p. 1969.
- 6) Imataka G, Yamanouchi H. Wolfram syndrome. Nippon Rinsho. 2002; 60:466-468.
- 7) Scolding NJ, Kellar-Wood HF, Shaw C, Sheenerson JM, Antoun N. Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol. 1996; 39:352-360.
- 8) Hofmann S, Bezold R, Jaksch M, et al. Analysis of the mitochondrial DNA from patients with Wolfram (DIDMOAD) syndrome. Mol Cell Biochem. 1997; 174:209-213.
- 9) Strom TM, Hortnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet. 1998; 7:2021-2028.
- 10) Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995; 346:1458-1463.
- 11) Domenech E, Gomez-Zaera M, Nunes V. Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. Pediatr Endocrinol Rev. 2006; 3:249-257.
- 12) Barrientos A, Casademont J, Saiz A, et al. Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet. 1996; 58:963-970.
- 13) Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol. 2002; 12:84-88.
- 14) Genis D, Davalos A, Molins A, Ferrer I. Wolfram syndrome: a neuropathological study. Acta Neuropathol. 1997; 93:426-429.
- 15) Hattori H, Inada H, Tanaka K, et al. Auditory brainstem responses (ABR) in patients with Wolfram syndrome. No To Hattatsu. 1998; 30:387-393. Esteban Bueno G, Gómez Trujillo FM. Clinical manifestations and diagnostic delay in Wolfram's syndrome. Rev Clin Esp. 2006; 206:332-335.